Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NAMS compared with AURA: revenue, margins and what each company keeps, and the suppliers and customers both name
NAMS
NewAmsterdam Pharma Co N.V.
Change
Mkt cap
Revenue
Revenue
AURA
Aura Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NAMS
NewAmsterdam Pharma Co N.V.
vs
AURA
Aura Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NAMS, solid
AURA, dashed
NAMS
NewAmsterdam Pharma Co N.V.
Change
19.99
▲
+2.21%
Mkt cap
$2.4B
Revenue
$4M
Q2 FY26
Revenue
$23M
FY25
AURA
Aura Biosciences, Inc.
Change
6.30
▲
+4.40%
Regular session
Nov 3 '26
Mkt cap
$636.7M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 3 '26
NAMS
NewAmsterdam Pharma Co N.V.
vs
AURA
Aura Biosciences, Inc.
19.99
▲
+2.21%
Price
6.30
▲
+4.40%
$2.4B
Mkt cap
$636.7M
Q2 FY26
$4M
Revenue
—
FY25
$23M
Revenue
—
Change
Change
NAMS
19.99
▲
+2.21%
vs
AURA
6.30
▲
+4.40%
Regular session
Nov 3 '26